Back
GoodRx Holdings Quote, Financials, Valuation and Earnings
Sponsored
GDRX
Sponsored
S&P Global: Private Equity Invests $36 Billion Into What?
Read More
Buy
63
GDRX
GoodRx Holdings
Last Price:
7.12
Seasonality Move:
-25.23%
7 Day Trial
ALL ACCESS PASS
$
7
Biden's Oil War: The Administration Is All-In on Green Energy.
Download Free ReportGoodRx Holdings Price Quote
$7.12
+0.12 (+1.71%)
(Updated: March 28, 2024 at 6:55 PM ET)
GoodRx Holdings Key Stats
Buy
63
GoodRx Holdings (GDRX)
is a Buy
Day range:
$6.90 - $7.23
52-week range:
$4.14 - $9.37
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.83
P/B ratio:
3.63%
Volume:
1.2M
Avg. volume:
1.7M
1-year change:
13.82%
Market cap:
$2.8B
Revenue:
$750.3M
EPS:
$-0.02
How Much Does GoodRx Holdings Make?
-
How Much Are GoodRx Holdings's Sales Annually?
GDRX Revenues are $750.3M -
How Much Profit Does GoodRx Holdings's Make A Year?
GDRX net income is -$8.9M
Is GoodRx Holdings Growing As A Company?
-
What Is GoodRx Holdings's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.07% -
What Is GoodRx Holdings's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
GoodRx Holdings Stock Price Performance
-
Did GoodRx Holdings Stock Go Up Last Month?
GoodRx Holdings share price went up by 6.22% last month -
Did GDRX's Share Price Rise Over The Last Year?
GDRX share price rose by 13.82% over the past 1 year
What Is GoodRx Holdings 52-Week High & Low?
-
What Is GoodRx Holdings’s 52-Week High Share Price?
GoodRx Holdings has traded as high as $9.37 over the past 52 weeks -
What Is GoodRx Holdings’s 52-Week Low Share Price?
GoodRx Holdings has traded as low as $4.14 over the past 52 weeks
GoodRx Holdings Price To Free Cash Flow
-
Is GoodRx Holdings Stock Overvalued?
GoodRx Holdings is trading at a price to free cash flow ratio of 34.85 -
Is GoodRx Holdings Stock Undervalued?
GoodRx Holdings EV to Free Cash Flow ratio is 33.31 -
What Is GoodRx Holdings’s Price Earnings Growth Ratio?
GDRX PEG ratio is 0.00 -
Is GoodRx Holdings Trading At A Premium To Earnings?
GoodRx Holdings EV to EBIT ratio is 2,378.18
Is It Risky To Buy GoodRx Holdings?
-
How Much Debt Does GoodRx Holdings Have?
Total long term debt quarterly is $656.5M -
How Much Cash Does GoodRx Holdings Have?
Cash and short term investments quarterly total is $672.3M -
What Is GoodRx Holdings’s Book Value Per Share?
Book value per share is 1.93
Is GoodRx Holdings Cash Flow Positive?
-
What Is GDRX Cash Flow From Operations?
Cash flow from operations (TTM) is $138.3M -
What Is GoodRx Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$167.4M -
What Is GoodRx Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$55.8M
GoodRx Holdings Return On Invested Capital
-
Is Management Doing A Good Job?
GDRX return on invested capital is -0.59% -
What Is GoodRx Holdings Return On Assets?
ROA measures how assets are converting to revenues and is -0.54% -
What Is GDRX Return On Equity?
ROE is a measure of profitability and is -1.06%
GoodRx Holdings Earnings Date & Stock Price
-
What Is GoodRx Holdings's Stock Price Today?
A single share of GDRX can be purchased today for 7.00 -
What Is GoodRx Holdings’s Stock Symbol?
GoodRx Holdings trades on the nasdaq under the ticker symbol: GDRX -
When Is GoodRx Holdings’s Next Earnings Date?
The next quarterly earnings date for GoodRx Holdings is scheduled on May 10, 2024 -
When Is GDRX's next ex-dividend date?
GoodRx Holdings's next ex-dividend date is March 29, 2024 -
How To Buy GoodRx Holdings Stock?
You can buy GoodRx Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
GoodRx Holdings Competitors
-
Who Are GoodRx Holdings's Competitors?
Below is a list of companies who compete with GoodRx Holdings or are related in some way:
GoodRx Holdings Dividend Yield
Data Unavailable
GoodRx Holdings Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 18.78% |
Revenue: | 6.81% | 0.39% |
Analyst Recommendations
Buy Recommendations: | 6 |
---|---|
Hold Recommendations: | 11 |
Sell Recommendations: | 0 |
Price Target: | 8.66 |
Upside from Last Price: | 23.73% |